A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017
Experimental Hematology and Oncology2021Vol. 10(1), pp. 11–11
Citations Over TimeTop 1% of 2021 papers
Mohammad Keykhaei, Masoud Masinaei, Esmaeil Mohammadi, Sina Azadnajafabad, Negar Rezaei, Sahar Saeedi Moghaddam, Nazila Rezaei, Maryam Nasserinejad, Mohsen Abbasi‐Kangevari, Mohammad‐Reza Malekpour, Seyyed‐Hadi Ghamari, Rosa Haghshenas, Kamyar Koliji, Farzad Kompani, Farshad Farzadfar
Abstract
The QCI provides a robust metric to evaluate the quality of care that empowers policymakers on their responsibility to allocate the resources effectively. We found that there is an association between development status and QCI and gender equity, indicating that instant policy attention is demanded to improve health-care access.
Related Papers
- → Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party(2010)49 cited
- → Presenting signs and symptoms in multiple myeloma: High percentages of stage III among patients without apparent myeloma-associated symptoms(1995)17 cited
- [Autologous transplantation of peripheral hematopoietic cells in a patient with multiple myeloma and renal insufficiency].(1997)
- Multiple myeloma with double clones of IgG-κ and IgG-λ: A case report and review of the literatures(2011)
- → Expression of MicroRNA-221 in Korean Patients with Multiple Myeloma(2018)